PMGC Holdings Inc. Files 8-K with Press Release
Ticker: ELAB · Form: 8-K · Filed: 2026-04-08T07:31:25-04:00
Sentiment: neutral
Topics: regulation-fd, press-release, filing
TL;DR
PMGC Holdings filed an 8-K on 4/8/26 with a press release. Check for updates.
AI Summary
PMGC Holdings Inc. filed an 8-K on April 8, 2026, to disclose information under Regulation FD. The filing includes a press release dated April 8, 2026, and financial statements and exhibits. The company is involved in the Pharmaceutical Preparations industry.
Why It Matters
This filing provides updated information and disclosures from PMGC Holdings Inc., which could impact investors' understanding of the company's current status and future prospects.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for Regulation FD disclosure and does not appear to contain any immediately alarming information.
Key Players & Entities
- PMGC Holdings Inc. (company) — Filer of the 8-K report
- 0001840563 (company) — CIK number for PMGC Holdings Inc.
- April 8, 2026 (date) — Filing date and date of press release
FAQ
What specific information was disclosed in the press release dated April 8, 2026?
The filing indicates a press release dated April 8, 2026, was included as Exhibit 99.1, but the content of the press release is not detailed in the provided text.
What is the primary business of PMGC Holdings Inc. according to the filing?
PMGC Holdings Inc. is primarily involved in Pharmaceutical Preparations, as indicated by its SIC code 2834.
What is the CIK number for PMGC Holdings Inc.?
The CIK number for PMGC Holdings Inc. is 0001840563.
When was this 8-K filing accepted by the SEC?
This 8-K filing was accepted by the SEC on April 8, 2026, at 07:31:25.
What items are covered in this 8-K filing?
This 8-K filing covers Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits).
From the Filing
EDGAR Filing Documents for 0001213900-26-041258 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 8-K - Current report: SEC Accession No. 0001213900-26-041258 Filing Date 2026-04-08 Accepted 2026-04-08 07:31:25 Documents 12 Period of Report 2026-04-08 Items Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits Interactive Data Document Format Files Seq Description Document Type Size 1 CURRENT REPORT ea0285475-8k_pmgc.htm iXBRL 8-K 25998 2 PRESS RELEASE DATED APRIL 8, 2026 ea028547501ex99-1.htm EX-99.1 14967 Complete submission text file 0001213900-26-041258.txt 210768 Data Files Seq Description Document Type Size 3 XBRL SCHEMA FILE elab-20260408.xsd EX-101.SCH 3026 4 XBRL LABEL FILE elab-20260408_lab.xml EX-101.LAB 34239 5 XBRL PRESENTATION FILE elab-20260408_pre.xml EX-101.PRE 22366 15 EXTRACTED XBRL INSTANCE DOCUMENT ea0285475-8k_pmgc_htm.xml XML 3205 Mailing Address 120 NEWPORT CENTER DRIVE NEWPORT BEACH CA 92660 Business Address 120 NEWPORT CENTER DRIVE NEWPORT BEACH CA 92660 888-445-4886 PMGC Holdings Inc. (Filer) CIK : 0001840563 (see all company filings) EIN. : 851399981 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-41875 | Film No.: 26846519 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)